MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4
Open Access
- 1 July 2016
- journal article
- retracted article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 9, 4705-4714
Abstract
Background/aim: Increasing evidence show microRNAs (miRNAs) are engaged in hepatocellular carcinoma (HCC). The aim of this study was to investigate the role of miR-144 in HCC, as well as to identify its underlying mechanism. Methods: The expression levels of miR-144 were assessed in multiple HCC cell lines, as well as in liver tissues from patients with HCC. We further examined the effects of miR-144 on HCC. The molecular target of miR-144 was identified using a computer algorithm and confirmed experimentally. Results: We found that the levels of miR-144 were frequently downregulated in human HCC tissues and cell lines, and overexpression of miR-144 dramatically inhibited HCC metastasis, invasion, cell cycle, epithelial–mesenchymal transition, and chemoresistance. We further verified the SMAD4 as a novel and direct target of miR-144 in HCCs. Conclusion: Taken together, overexpression of miR-144 or downregulation of SMAD4 may prove beneficial as therapeutic strategies for HCC treatment.Keywords
This publication has 27 references indexed in Scilit:
- Meta-analysis of the differentially expressed breast cancer-related microRNA expression profilesJournal of Obstetrics and Gynaecology, 2014
- MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9XBMC Cancer, 2014
- miR‐144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signalingThe FEBS Journal, 2013
- The microcosmos of cancerNature, 2012
- Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-β Signaling in HepatocarcinogenesisDigestive Diseases, 2011
- Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cellsCarcinogenesis, 2010
- Strong Smad4 Expression Correlates with Poor Prognosis After Surgery in Patients with Hepatocellular CarcinomaAnnals of Surgical Oncology, 2009
- Biology of transforming growth factor ? in hepatocarcinogenesisMicroscopy Research and Technique, 2001
- The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosisGenes & Development, 2001
- Smad2 and Smad4 gene mutations in hepatocellular carcinomaOncogene, 1999